Fig. 2: Mutational profiles of CTCs, matched tumour biopsies and cfDNA at combined dabrafenib plus trametinib therapy failure.
Variants in red are known or predicted as drivers according to Cancer Genome Interpreter.
Fig. 2: Mutational profiles of CTCs, matched tumour biopsies and cfDNA at combined dabrafenib plus trametinib therapy failure. | British Journal of Cancer
